VENTAS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 50.04 USD | +1.05% |
|
+0.40% | +0.40% |
| Jun. 13 | BMO Capital Adjusts Price Target on Ventas to $57 From $53, Keeps Outperform Rating | MT |
| Jun. 12 | Scotiabank Adjusts Price Target on Ventas to $52 From $51 | MT |
Financials (USD)
| Sales 2024 * | 4.84B | Sales 2025 * | 5.12B | Capitalization | 20.01B |
|---|---|---|---|---|---|
| Net income 2024 * | 3M | Net income 2025 * | 115M | EV / Sales 2024 * | 6.8 x |
| Net Debt 2024 * | 12.89B | Net Debt 2025 * | 12.86B | EV / Sales 2025 * | 6.42 x |
| P/E ratio 2024 * |
1,000
x | P/E ratio 2025 * |
188
x | Employees | 486 |
| Yield 2024 * |
3.68% | Yield 2025 * |
3.85% | Free-Float | 99.39% |
More Fundamentals
* Assessed data
More news
Latest transcript on Ventas, Inc.
More recommendations
More news
| 1 day | +1.05% | ||
| 1 week | +0.40% | ||
| Current month | -0.44% | ||
| 1 month | +5.10% | ||
| 3 months | +15.30% | ||
| 6 months | +3.39% | ||
| Current year | +0.40% |
1 week
49.06
50.68
1 month
46.6650.68
Current year
41.4550.68
1 year
39.3350.99
3 years
35.3364.02
5 years
13.3575.40
10 years
13.3581.93
| Managers | Title | Age | Since |
|---|---|---|---|
Debra Cafaro
CEO | Chief Executive Officer | 66 | 98-12-31 |
Bob Probst
DFI | Director of Finance/CFO | 56 | 14-10-26 |
| Chief Tech/Sci/R&D Officer | - | 19-01-24 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michael Embler
BRD | Director/Board Member | 60 | 22-03-06 |
Matthew Lustig
BRD | Director/Board Member | 63 | 11-05-11 |
Marguerite Nader
BRD | Director/Board Member | 55 | 20-07-05 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.03% | 120 M€ | -.--% | ||
| 1.91% | 255 M€ | -2.88% | ||
| 1.43% | 138 M€ | +5.61% | ||
| 0.99% | 0 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-12 | 49.52 | -0.14% | 2,082,782 |
| 24-06-11 | 49.59 | -0.62% | 2,054,683 |
| 24-06-10 | 49.9 | +0.38% | 1,536,742 |
| 24-06-07 | 49.71 | -0.26% | 1,489,669 |
| 24-06-06 | 49.84 | +0.14% | 1,808,603 |
Delayed Quote Nyse, June 13, 2024 at 04:00 pm EDT
More quotes
Ventas, Inc. specializes in owning and managing healthcare and medical-residential facilities.
At the end of 2022, the group's portfolio included 1,237 assets consisting primarily of senior housing (802), medical office buildings (313), rehabilitation and long-term acute care facilities (36), laboratories and research facilities (32), skilled nursing facilities (16), medical and surgical facilities (13).
Net sales are distributed geographically as follows: the United States (88.5%), Canada (10.9%) and the United Kingdom (0.6%).
Sector
Specialized REITs
Calendar
2024-06-30
- Détachement de
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
49.52
USD
Average target price
53.68
USD
Spread / Average Target
+8.40%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +0.40% | 20.01B | |
| +15.19% | 61.51B | |
| +4.73% | 7.86B | |
| -3.95% | 6.26B | |
| +12.96% | 3.65B | |
| -0.21% | 3.28B | |
| -9.98% | 2.99B | |
| -1.63% | 2.9B | |
| +18.16% | 2.84B | |
| -18.98% | 2.42B |
- Stock Market
- Equities
- VTR Stock
